UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Apella Capital LLC

Apella Capital LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 37.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,120 shares of the healthcare conglomerate’s stock after purchasing an additional 304 shares during the quarter. Apella Capital LLC’s holdings in UnitedHealth Group were worth $551,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Delos Wealth Advisors LLC raised its position in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $31,000. Red Tortoise LLC increased its holdings in shares of UnitedHealth Group by 45.1% in the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 23 shares during the period. Ruedi Wealth Management Inc. increased its holdings in shares of UnitedHealth Group by 58.3% in the 1st quarter. Ruedi Wealth Management Inc. now owns 76 shares of the healthcare conglomerate’s stock valued at $38,000 after purchasing an additional 28 shares during the period. Finally, Transcendent Capital Group LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on UNH. JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. HSBC upped their target price on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Truist Financial upped their target price on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Finally, Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $614.17.

UnitedHealth Group Price Performance

Shares of UNH stock traded down $1.97 during trading hours on Wednesday, hitting $566.38. 4,320,731 shares of the company’s stock were exchanged, compared to its average volume of 4,301,266. The stock’s 50-day moving average is $517.25 and its 200-day moving average is $503.83. The stock has a market cap of $521.29 billion, a price-to-earnings ratio of 34.74, a price-to-earnings-growth ratio of 1.64 and a beta of 0.59. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $591.54. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the business earned $6.14 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.48%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.